INTEGRIN MODULATING FACTOR-I - A LIPID THAT ALTERS THE FUNCTION OF LEUKOCYTE INTEGRINS

被引:153
作者
HERMANOWSKIVOSATKA, A
VANSTRIJP, JAG
SWIGGARD, WJ
WRIGHT, SD
机构
[1] The Rockefeller University New York
关键词
D O I
10.1016/0092-8674(92)90475-R
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The avidity of integrin CR3 (also known as alpha(M)beta-2, Mac-1, Mo-1, and CD11b/CD18) may be reversibly altered without changes in the number of cell surface receptors. Here we describe a molecule termed integrin modulating factor (IMF-1), which controls CR3 avidity. Addition of IMF-1 to polymorphonuclear leukocytes (PMNs) or to purified CR3 causes enhanced binding of ligand. IMF-1 is not present in resting PMNs, but stimulation of cells results in a transient rise in IMF-1 content that parallels a transient rise in CR3 activity. We suggest that PMNs control adhesivity by controlling synthesis of IMF-1, which then acts as an allosteric activator of leukocyte integrins. IMF-1 is an acidic, amphiphilic molecule of M(r) 340 +/- 16 that does not contain ester, phosphate, amide, sialic acid, or glycosidic or vicinal hydroxyl functionalities, but does contain a carbon-carbon double bond. These results suggest that IMF-1 is an unsaturated fatty acid or an isoprenoid acid.
引用
收藏
页码:341 / 352
页数:12
相关论文
共 61 条
[21]  
HARLAN JM, 1985, BLOOD, V66, P167
[22]  
HENSON PM, 1988, INFLAMMATION BASIC P, P363
[23]  
HERMANOWSKIVOSATKA A, 1988, J BIOL CHEM, V263, P17822
[24]  
KEIZER GD, 1988, J IMMUNOL, V140, P1393
[25]   DIRECT EVIDENCE THAT GANGLIOSIDE IS AN INTEGRAL COMPONENT OF THE THYROTROPIN RECEPTOR [J].
KIELCZYNSKI, W ;
HARRISON, LC ;
LEEDMAN, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (05) :1991-1995
[26]  
KOUNS WC, 1990, J BIOL CHEM, V265, P20594
[27]   P150/95, 3RD MEMBER OF THE LFA-1/CR3 POLYPEPTIDE FAMILY IDENTIFIED BY ANTI-LEU M5 MONOCLONAL-ANTIBODY [J].
LANIER, LL ;
ARNAOUT, MA ;
SCHWARTING, R ;
WARNER, NL ;
ROSS, GD .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1985, 15 (07) :713-718
[28]  
LEFKOWITH JB, 1988, J IMMUNOL, V140, P228
[29]  
LEFKOWITH JB, 1991, J BIOL CHEM, V266, P1071
[30]  
LINDSTROM P, 1988, J CLIN LAB IMMUNOL, V25, P77